ScreenerHero

RUA RUA Life Sciences plc

LSE · GB · Healthcare · Medical Devices · rualifesciences.com
28.50GBp0.00%Mkt Cap: 19.23M $P/E: —

RUA Life Sciences plc, together with its subsidiaries, develops medical devices in Europe, North America, the Middle East, the Asia Pacific, and Africa. It operates through four segments: Biomaterials, Contract Manufactu…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$174.36BUSDP/E 32.3
MDT
Medtronic plc
$112.53BUSDP/E 21.6
SYK
Stryker Corporation
$109.40BUSDP/E 29.6
BSX
Boston Scientific Corporation
$61.45BUSDP/E 17.2
EW
Edwards Lifesciences Corporation
$50.23BUSDP/E 51.9
SHL
Siemens Healthineers AG
$46.06BUSDP/E 19.2
DXCM
DexCom, Inc. - Common Stock
$32.21BUSDP/E 33.7
GEHC
GE HealthCare Technologies Inc. - Common Stock
$29.24BUSDP/E 14.8
PHG
Koninklijke Philips N.V.
$23.37BUSDP/E 17.8
PHIA
Koninklijke Philips N.V.
$22.58BUSDP/E 18.5
STE
STERIS plc
$20.58BUSDP/E 25.8
SOON
Sonova Holding AG
$17.06BUSDP/E 27.9
ZBH
Zimmer Biomet Holdings, Inc.
$17.47BUSDP/E 22.2
PEN
Penumbra, Inc.
$12.49BUSDP/E 77.9
TXG
10x Genomics, Inc. - Common Stock
$12.18BUSD
SNN
Smith & Nephew plc
$11.27BUSDP/E 18.3
GMED
Globus Medical, Inc.
$10.28BUSDP/E 19.6
BIO
Bio-Rad Laboratories, Inc.
$10.16BUSDP/E 48.1
DEMANT
Demant A/S
$9.81BUSDP/E 27.8
GKOS
Glaukos Corporation
$9.67BUSD

Key Statistics

Company
Market Cap19.23M USD
Enterprise Value17.40M USD
Revenue (TTM)5.02M USD
Gross Profit1.93M USD
Net Income (TTM)-1.57M USD
Revenue/Share0.07 GBp
Last Price28.50 GBp
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees59
CountryGB
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-71.25
PEG—
EV/EBITDA27.85
EV/Revenue3.47
P/S3.83
P/B2.52
EPS (TTM)0.00
EPS (Forward)-0.00
52W Range
10.5088% of range31.00
52W High31.00 GBp
52W Low10.50 GBp
Profitability
Gross Margin81.06%
Oper. Margin-8.52%
EBITDA Margin12.45%
Profit Margin-65.72%
ROE-20.05%
ROA-17.63%
Growth
Revenue Growth6.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.44M USD
CapEx (TTM)59.78K USD
FCF Margin—
FCF Yield—
Net Debt-1.86M USD
Net Debt/EBITDA-2.98
Balance Sheet
Debt/Equity0.05
Current Ratio5.92
Quick Ratio4.44
Book Value/Sh0.11 GBp
Cash/Share0.04 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 GBp
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateSep 1, 2003
Analyst Consensus
Rating—
Target (Mean)50.00 GBp
Upside (mean)+75.4%
Target Range50.00 GBp – 50.00 GBp
# Analysts1
Ownership
Shares Out.62.06M
Float50.42M
Insiders19.16%
Institutions17.58%
Technical
SMA 5026.85 (+6.1%)
SMA 20019.52 (+46.0%)
Beta0.99
S&P 52W Chg14.58%
Avg Vol (30d)171.11K
Avg Vol (10d)237.13K
Technical Indicators
RSI (14)54.8
MACD0.6773
MACD Signal0.7829
MACD Hist.-0.1055
BB Upper29.96 GBp
BB Middle28.20 GBp
BB Lower26.44 GBp
BB Width12.48%
ATR (14)1.721 GBp
Vol Ratio (20d)0.85x